Published in Psychopharmacologia on January 01, 1975
Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. Br J Pharmacol (1975) 1.38
Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker. Br J Pharmacol (1983) 0.83
Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan. Br J Pharmacol (1988) 0.81
Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice. Br J Pharmacol (1984) 0.80
Benzodiazepine receptors in rat brain. Nature (1977) 3.29
Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A (1977) 3.13
High densities of benzodiazepine receptors in human cortical areas. Nature (1977) 1.97
[35S]t-butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to gamma-aminobutyric acid-A and ion recognition sites. Mol Pharmacol (1983) 1.59
Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species. Adv Biochem Psychopharmacol (1972) 1.43
Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase. J Pharm Pharmacol (1974) 1.23
Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol Biochem Behav (1979) 1.19
Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol (1978) 1.18
Potent and long-lasting potentiation of two 5-hydroxytryptophan- induced effects in mice by three selective 5-ht uptake inhibitors. Eur J Pharmacol (1978) 1.02
Additional evidence for the existence of several forms of mitochondrial monoamine oxidase in the mouse. Biochem Pharmacol (1968) 1.02
Evidence for a late evolutionary appearance of brain-specific benzodiazepine receptors: an investigation of 18 vertebrate and 5 invertebrate species. Brain Res (1978) 1.01
The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction. Psychopharmacologia (1974) 1.00
Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sci (1984) 0.98
Pharmacological and biochemical studies on 2-amino-4-phenylsulphonylbenzenesulphonamide (NSD 3004): a new sulphonamide with anticonvulsant and carbonic anhydrase inhibitory properties. Acta Pharmacol Toxicol (Copenh) (1971) 0.96
Brain specific benzodiazepine receptors. Br J Psychiatry (1978) 0.93
GABAA receptor blockers reverse the inhibitory effect of GABA on brain-specific [35S]TBPS binding. Brain Res (1987) 0.87
Benzodiazepine receptor multiplicity. Neuropharmacology (1983) 0.87
Evidence that 5-methoxy-N, N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: implications for the indoleamine dependent behavioural syndrome. J Neurochem (1975) 0.85
Mono N-aryl ethylenediamine and piperazine derivatives are GABAA receptor blockers: implications for psychiatry. Neurochem Res (1993) 0.85
Some pharmacological and biochemical properties of gamma-morpholino-butyrophenone (NSD 2023), a new monoamine oxidase inhibitor. Biochem Pharmacol (1968) 0.82
Enhancement of 3H-diazepam binding by SQ 65,396: a novel anti-anxiety agent. Pharmacol Biochem Behav (1978) 0.82
Pharmacological and toxicological studies on gamma-(4-methylpiperidino)-p-fluorobutyrophenone (FG 5111)--a new neuroleptic agent. Acta Pharmacol Toxicol (Copenh) (1965) 0.81
Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant properties. Psychopharmacologia (1975) 0.80
The effect of amantadine and (+)-amphetamine on motility in rats after inhibition of monoamine synthesis and storage. Psychopharmacologia (1973) 0.79
Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics. Acta Pharmacol Toxicol (Copenh) (1979) 0.78
Antagonistic effects of neuroleptics and apomorphine on synaptosomal tyrosine hydroxylase in vitro. J Pharm Pharmacol (1974) 0.78
Characteristics and regional distributions of two distinct [3H]naloxone binding sites in the rat brain. J Neurochem (1978) 0.78
No changes in rat benzodiazepine receptors after withdrawal from continuous treatment with lorazepam and diazepam. Life Sci (1979) 0.77
Effects of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase-A and on GABAA receptors. Neurochem Res (1996) 0.77
Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics. Eur J Pharmacol (1975) 0.77
A water lick conflict paradigm using drug experienced rats. Psychopharmacology (Berl) (1981) 0.77
Behavioural effects of d-amphetamine in young chicks treated with p-Cl-phenylalanine. Psychopharmacologia (1971) 0.77
gamma-aminobutyric acid receptors modulate cation binding sites coupled to independent benzodiazepine, picrotoxin, and anion binding sites. Mol Pharmacol (1982) 0.77
The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding. J Neural Transm Suppl (1998) 0.76
Saturable binding of 35S-t-butylbicyclophosphorothionate to the sites linked to the GABA receptor and the interaction with GABAergic agents. Life Sci (1984) 0.76
GABA receptors regulate the affinities of anions required for brain specific benzodiazepine binding. Adv Biochem Psychopharmacol (1981) 0.76
Excitatory amino acids: role in morphine excitation in rat periaqueductal gray. Behav Brain Res (1988) 0.76
Non-stereospecific excitatory actions of morphine may be due to GABA-A receptor blockade. Eur J Pharmacol (1987) 0.75
Influence of the new 5-HT-uptake inhibitor paroxetine on hypermotility in rats produced by p-chloroamphetamine (PCA) and 4,alpha-dimethyl-7-tyramine (H 77/77). Psychopharmacology (Berl) (1978) 0.75
Some properties of particle-bound monoamine oxidase from human whole blood. Biochem Pharmacol (1977) 0.75
Are polioviruses a cause of schizophrenia? Br J Psychiatry (1992) 0.75
Elimination and distribution of menbutone (Genabil) in rats. Acta Pharmacol Toxicol (Copenh) (1969) 0.75
Hyperthermia- and L-tryptophan-induced increases in serotonin turnover in rat brain. Adv Biochem Psychopharmacol (1974) 0.75
Inhibition of both MAO-A and MAO-B required for the production of hypermotility in mice with the 5HT uptake inhibitors chlorimipramine and femoxetine. Neuropharmacology (1977) 0.75
Effects of 5HT uptake inhibitors on the pressor response to 5HT in the pithed rat. The significance of the 5HT blocking property. Eur J Pharmacol (1977) 0.75
Potentiation of nialamide-induced hypermotility in mice by lithium and the 5-HT uptake inhibitors chlorimipramine and FG 4963. Neuropharmacology (1976) 0.75
Evidence for a noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4, alpha-dimethyl-m-tyramine (H 77/77) in rats. Psychopharmacology (Berl) (1977) 0.75
Multiple benzodiazepine receptor complexes: some benzodiazepine recognition sites are coupled to GABA receptors and ionophores. Adv Biochem Psychopharmacol (1980) 0.75
Iontophoretic studies on rat hippocampus with some novel GABA antagonists. Life Sci (1986) 0.75
omega-Conotoxin binding sites and regulation of transmitter release in cerebellar granule neurons. J Neurosci Res (1994) 0.75
Effects of noradrenaline pump blockers on its uptake by synaptosomes from several brain regions; additional evidence for dopamine terminals in the frontal cortex. J Pharm Pharmacol (1974) 0.75
Inhibition and potentiation of apomorphine-induced hypermotility in rats by neuroleptics. Eur J Pharmacol (1976) 0.75
Neuronal localisation of benzodiazepine receptors in cerebellum. Neurosci Lett (1979) 0.75
Differential inhibition of brain specific [3H]flunitrazepam binding by several types of dyes. Neurochem Res (1983) 0.75
Benzodiazepine receptor in brain. Acta Psychiatr Scand Suppl (1978) 0.75
Introduction to the development of paroxetine, a novel antidepressant. Acta Psychiatr Scand Suppl (1989) 0.75
Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats. Psychopharmacologia (1974) 0.75
The distribution of 2-amino-4-phenylsulphonylbenzenesulphonamide (NSD 3004) in blood and its binding to blood components. Acta Pharmacol Toxicol (Copenh) (1971) 0.75
Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine. Psychopharmacology (Berl) (1980) 0.75
Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone. Acta Pharmacol Toxicol (Copenh) (1977) 0.75
Lack of brain specific benzodiazepine receptors on mouse primary astroglial cultures. Neurosci Lett (1978) 0.75